Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon monotherapy in chronic hepatitis B.

R Guan1

  • 1Mount Elizabeth Medical Centre and National University Hospital Singapore, Singapore. rgyc5@singnet.com.sg

Journal of Gastroenterology and Hepatology
|August 2, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Influence of operator's experience on the quality and success rate of root canal treatment with new nickel-titanium instruments].

Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology·2024
Same author

Impact of shift work on dementia: a systematic review and dose-response meta-analysis.

Public health·2023
Same author

Study for the binding affinity of thyroid hormone receptors based on machine learning algorithm.

SAR and QSAR in environmental research·2022
Same author

A Knowledge Base Completion Model Based on Path Feature Learning.

International journal of computers, communications & control·2022
Same author

Using artificial intelligence algorithms to identify existing knowledge within the back pain literature.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2020
Same author

Chitinase-like protein YKL-40 regulates human bronchial epithelial cells proliferation, apoptosis, and migration through TGF-β1/Smads pathway.

Human & experimental toxicology·2019
Same journal

Comment on "Association of Proton Pump Inhibitor and Potassium-Competitive Acid Blocker Use With Discontinuation and Intolerance of Oral 5-Aminosalicylic Acid in Patients With Ulcerative Colitis".

Journal of gastroenterology and hepatology·2026
Same journal

Response to Dileep et al. Regarding the J-GESS Score.

Journal of gastroenterology and hepatology·2026
Same journal

Methodological Considerations Regarding Organ-Preserving Strategies for Malignant Colorectal Polyps.

Journal of gastroenterology and hepatology·2026
Same journal

Predicting Remnant Tumor After Incomplete Resection of Rectal Neuroendocrine Tumors: The KASID Multicenter Retrospective Cohort Study.

Journal of gastroenterology and hepatology·2026
Same journal

Response to Un Nisa et al. Regarding the J-GESS Score.

Journal of gastroenterology and hepatology·2026
Same journal

Patient-Level Predictors of Procedural Success in Colon Capsule Endoscopy: A Systematic Review and Meta-Analysis.

Journal of gastroenterology and hepatology·2026
See all related articles

Interferon-alpha (IFN-alpha) offers limited efficacy for chronic hepatitis B, with side effects and low response rates in certain patients. Favorable responses are linked to elevated ALT and low HBV DNA levels.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Interferon-alpha (IFN-alpha) has been a primary treatment for chronic hepatitis B.
  • Its use is declining due to limitations in efficacy, side effects, and cost.
  • IFN-alpha is ineffective in patients with minimal liver inflammation.

Purpose of the Study:

  • To evaluate the efficacy and response predictors of Interferon-alpha therapy for chronic hepatitis B.
  • To compare treatment outcomes across different patient demographics and disease stages.

Main Methods:

  • Analysis of treatment outcomes in patients receiving IFN-alpha for chronic hepatitis B.
  • Identification of factors predicting response, including ALT levels and HBV DNA viral load.
  • Comparison of response rates in various patient groups (e.g., children, Caucasians, Chinese patients, HBeAg-negative patients).

Related Experiment Videos

Main Results:

  • IFN-alpha treatment resulted in HBsAg loss and suppressed viral replication in a minority of patients (6% and 20% respectively).
  • Elevated ALT levels and low serum HBV DNA were key predictors of a favorable response.
  • Similar response rates were observed in Chinese patients and children compared to Caucasian adults with comparable ALT levels.
  • Patients with HBeAg-negative chronic hepatitis B showed poorer treatment outcomes.

Conclusions:

  • Interferon-alpha has a limited role in chronic hepatitis B treatment due to modest efficacy and specific response predictors.
  • While most responders maintain their status, complete eradication of HBV is rare.
  • Newer therapeutic strategies are needed to improve outcomes for chronic hepatitis B patients.